耳鼻咽喉科機器 - 世界市場の考察、競合情勢、市場予測（2030年）

世界の耳鼻咽喉科機器の市場規模は、2023年に168億米ドル、2030年までに250億2,000万米ドルに達し、2024年～2030年の予測期間にCAGRで6.89％の成長が見込まれます。市場の成長は、怪我、ウイルスや細菌の感染、がん、アレルギー性鼻炎などの慢性疾患、老年人口の増加により、耳鼻咽喉のさまざまな問題が増加しているためです。難聴の症例の増加も、耳鼻咽喉科機器市場の主な成長促進要因です。低侵襲手術用耳鼻咽喉科機器に向けたさまざまな技術開発も、この市場の成長要因です。長年にわたる形成外科手術のブームも、効果的な耳鼻咽喉科機器へのニーズの向上を明らかにしています。

耳鼻咽喉科機器の市場力学

耳鼻咽喉科機器の成長は、慢性疾患、怪我、感染症、高齢化などのさまざまな要因によるものです。

徹底的な診断と腫瘍の除去に手術が必要な頭頸部がんの有病率の上昇は、市場成長の重大な要因です。National Cancer Institute（2022）によると、米国における全がん症例のうち、頭頸部がんの症例は4％を占めています。また、耳鼻咽喉の健康に影響を及ぼす細菌やウイルスの感染が世界中で増加していることも、耳鼻咽喉科の診断/手術機器の需要の増加の原因となっています。例えば、2022年に発表された世界保健機関（WHO）のデータによると、細菌性髄膜炎から回復した後、個人が聴力、言語、コミュニケーションの喪失などの長期的な影響に直面する確率は5人に1人です。加えて、年齢が上がるにつれて聴力が低下するため、補聴器やインプラントなどの早急な対策が必要となり、そのために手術が行われます。このことも市場の成長につながります。

耳鼻咽喉科機器市場の成長のもう1つの主な要因は、手頃なコストで効果的かつ低侵襲な手術を行うための新たな技術開発です。例えば、ジョージア工科大学の研究者は、加齢による難聴に悩む何百万人もの人々を救うため、手頃な超低コストの補聴器を開発しました。

座りっぱなしのライフスタイルは、閉塞性睡眠時無呼吸症候群やその他の呼吸問題を含む生活習慣病を引き起こすことから、耳鼻咽喉科機器市場のもう1つの成長促進要因となっています。American Academy of Sleep Medicineによると、約3,000万人のアメリカ人成人が閉塞性睡眠時無呼吸症候群（OSA）に苦しんでいます。アレルギー性鼻炎を含む急性および慢性の季節性アレルギーの症例や、特定のアレルゲンによる副鼻腔炎も、耳鼻咽喉科機器市場にプラスの影響を与えています。World Allergy Organization（2020）の最新のデータによると、現在世界中で約4億人がアレルギー性鼻炎に苦しんでおり、そのほとんどが診断も治療も受けていません。

耳鼻咽喉科機器市場もまた、世界の美容整形手術の増加によりプラス成長を示しています。人々は外見の美しさを求めるようになり、低侵襲で安全な手術が手頃な価格で受けられるようになったことが、美容整形産業をさらに活性化させ、耳鼻咽喉科機器市場の成長もかなりのものとなっています。

しかし、発展途上国における手頃な耳鼻咽喉科製品へのアクセスの制約や、熟練した耳鼻咽喉科専門医の不足が、耳鼻咽喉科機器市場の主な成長抑制要因となっています。

COVID-19パンデミックの期間中、耳鼻咽喉科機器市場の成長は、COVID-19患者を最初に治療することに主眼が移されたため、若干の落ち込みを見せました。パンデミック中、病院はロックダウンにより、また感染拡大の可能性を避けるために耳鼻咽喉科を閉鎖しました。しかし、COVID-19後すべてが正常化し、耳鼻咽喉科の健康や定期検診に対する社会の意識が高まるにつれて、耳鼻咽喉科手術が増加しています。したがって、2024年～2030年の予測期間に市場は効果的に成長する見込みです。

当レポートでは、世界の耳鼻咽喉科機器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 耳鼻咽喉科機器市場レポートのイントロダクション

第2章 耳鼻咽喉科機器市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価
• 財務ベンチマーク

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 耳鼻咽喉科機器市場の主な要因の分析

• 耳鼻咽喉科機器市場の促進要因
  • 耳鼻咽喉関連の問題の増加
  • 老年人口の増加
  • 技術の進歩
  • 美容整形の増加
• 耳鼻咽喉科機器市場の抑制要因と課題
  • 熟練した耳鼻咽喉科専門医の不足
  • 耳鼻咽喉科機器に関連する合併症
• 耳鼻咽喉科機器市場の機会
  • 製品の安全性の向上
  • 手頃な価格の耳鼻咽喉科製品

第5章 耳鼻咽喉科機器市場のポーターのファイブフォース分析

第6章 耳鼻咽喉科機器市場に対するCOVID-19の影響分析

第7章 耳鼻咽喉科機器市場のレイアウト

• 機器タイプ別
  • 診断用耳鼻咽喉科機器
  • 手術用耳鼻咽喉科機器
  • 補聴器
  • 聴覚インプラント
  • 鼻スプリント
  • その他
• 処置別
  • 喉頭鏡検査
  • 機能的内視鏡副鼻腔手術
  • 扁桃摘出術、アデノイド切除術
• 使用性別
  • 使い捨て
  • 再使用可能
• 年齢層別
  • 小児
  • 成人
• エンドユーザー別
  • 病院
  • 耳鼻咽喉科クリニック
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 耳鼻咽喉科機器市場：世界の企業シェア分析 - 主要3～5社

第9章 耳鼻咽喉科機器市場の企業と製品のプロファイル

• Medtronic
• Starkey
• Johnson & Johnson Services, Inc.
• Smith and Nephew Plc.
• Fude Technology Group Limited
• Cochlear Limited
• Olympus America
• Stryker Corporation
• Sonova Holding AG
• Atos medical Ab
• MED-EL Medical Electronics
• Firefly Global
• RION Co., Ltd.
• GN Store Nord A/S
• Welch Allyn®
• Karl Storz Gmbh & co.
• Demant A/S
• B. Braun Melsungen AG
• WS Audiology A/S
• PENTAX Medical

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on ENT Devices Market
• Table 3: ENT Devices Market in Global (2021-2030)
• Table 4: ENT Devices Market in Global by Device Type (2021-2030)
• Table 5: ENT Devices Market in Global by Procedure Type (2021-2030)
• Table 6: ENT Devices Market in Global by Usability (2021-2030)
• Table 7: ENT Devices Market in Global by Age Group (2021-2030)
• Table 8: ENT Devices Market in Global by End-user (2021-2030)
• Table 9: ENT Devices Market in Global by Geography (2021-2030)
• Table 11: ENT Devices Market in North America (2021-2030)
• Table 12: ENT Devices Market in North America by Country (2021-2030)
• Table 13: ENT Devices Market in the US (2021-2030)
• Table 14: ENT Devices Market in Canada (2021-2030)
• Table 15: ENT Devices Market in Mexico (2021-2030)
• Table 16: ENT Devices Market in Europe (2021-2030)
• Table 17: ENT Devices Market in Europe by Country (2021-2030)
• Table 18: ENT Devices Market in France (2021-2030)
• Table 19: ENT Devices Market in Germany (2021-2030)
• Table 20: ENT Devices Market in the United Kingdom (2021-2030)
• Table 21: ENT Devices Market in Italy (2021-2030)
• Table 22: ENT Devices Market in Spain (2021-2030)
• Table 23: ENT Devices Market in Russia (2021-2030)
• Table 24: ENT Devices Market in Rest of Europe (2021-2030)
• Table 25: ENT Devices Market in APAC (2021-2030)
• Table 26: ENT Devices Market in APAC by Country (2021-2030)
• Table 27: ENT Devices Market in China (2021-2030)
• Table 28: ENT Devices Market in Japan (2021-2030)
• Table 29: ENT Devices Market in India (2021-2030)
• Table 30: ENT Devices Market in Australia (2021-2030)
• Table 31: ENT Devices Market in South Korea (2021-2030)
• Table 32: ENT Devices Market in Rest of APAC (2021-2030)
• Table 33: ENT Devices Market in Rest of World (2021-2030)
• Table 34: ENT Devices Market in RoW by Region (2021-2030)
• Table 35: ENT Devices Market in Middle East (2021-2030)
• Table 36: ENT Devices Market in Africa (2021-2030)
• Table 37: ENT Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on ENT Devices Market
• Figure 3: ENT Devices Market in Global (2021-2030)
• Figure 4: ENT Devices Market in Global by Device Type (2021-2030)
• Figure 5: ENT Devices Market in Global by Procedure Type (2021-2030)
• Figure 6: ENT Devices Market in Global by Usability (2021-2030)
• Figure 7: ENT Devices Market in Global by Age Group (2021-2030)
• Figure 8: ENT Devices Market in Global by End-user (2021-2030)
• Figure 9: ENT Devices Market in Global by Geography (2021-2030)
• Figure 10: ENT Devices Market in North America (2021-2030)
• Figure 11: ENT Devices Market in North America by Country (2021-2030)
• Figure 12: ENT Devices Market in the US (2021-2030)
• Figure 13: ENT Devices Market in Canada (2021-2030)
• Figure 14: ENT Devices Market in Mexico (2021-2030)
• Figure 15: ENT Devices Market in Europe (2021-2030)
• Figure 16: ENT Devices Market in Europe by Country (2021-2030)
• Figure 17: ENT Devices Market in France (2021-2030)
• Figure 18: ENT Devices Market in Germany (2021-2030)
• Figure 19: ENT Devices Market in the United Kingdom (2021-2030)
• Figure 20: ENT Devices Market in Italy (2021-2030)
• Figure 21: ENT Devices Market in Spain (2021-2030)
• Figure 22: ENT Devices Market in Russia (2021-2030)
• Figure 23: ENT Devices Market in Rest of Europe (2021-2030)
• Figure 24: ENT Devices Market in APAC (2021-2030)
• Figure 25: ENT Devices Market in APAC by Country (2021-2030)
• Figure 26: ENT Devices Market in China (2021-2030)
• Figure 27: ENT Devices Market in Japan (2021-2030)
• Figure 28: ENT Devices Market in India (2021-2030)
• Figure 29: ENT Devices Market in Australia (2021-2030)
• Figure 30: ENT Devices Market in South Korea (2021-2030)
• Figure 31: ENT Devices Market in Rest of APAC (2021-2030)
• Figure 32: ENT Devices Market in Rest of World (2021-2030)
• Figure 33: ENT Devices Market in RoW by Region (2021-2030)
• Figure 34: ENT Devices Market in Middle East (2021-2030)
• Figure 35: ENT Devices Market in Africa (2021-2030)
• Figure 36: ENT Devices Market in South America (2021-2030)
• Figure 37: Market Drivers
• Figure 38: Market Barriers
• Figure 39: Marker Opportunities
• Figure 40: PORTER'S Five Force Analysis

ENT Devices Market By Device Type (Diagnostic ENT Devices, Surgical ENT Devices, Hearing Aids, Hearing Implants, Nasal Splints, And Others) Procedure Type (Laryngoscopy, Functional Endoscopic Sinus Surgery, Tonsillectomy, Adenoidectomy, And Others) By Usability (Disposable And Reusable) By Age Group (Pediatric And Adults) By End-User (Hospitals, ENT Clinics, And Others) by geography is estimated to register a significant growth during the forecast period from 2024-2030 owing to surge in prevalence of ENT problems and technological advances in ENT devices.

The global ENT devices market was valued at USD 16.80 billion in 2023, growing at a CAGR of 6.89% during the forecast period from 2024 to 2030 to reach USD 25.02 billion by 2030. The positive growth in the ENT devices market is due to the rising prevalence of various Ear, Nose, and Throat problems as a result of injuries, viral and bacterial infections, chronic diseases like cancer, allergic rhinitis, and an increasing geriatric population. The growing cases of hearing loss or deafness are another major driver driving the market growth of ENT devices. The various technological developments for minimally invasive surgical ENT devices are another matter of fact for the growth of this market. The boom in plastic surgeries over many years also explains the growing need for effective ENT devices.

ENT Devices Market Dynamics:

The growth of ENT devices is owing to various factors including chronic diseases, injuries, infections, increasing age, and others.

The rising prevalence of head and neck cancer which requires thorough diagnosis and surgery for removal of the tumour is an important factor for market growth. According to National Cancer Institute 2022, out of total cancer cases in the US, the cases of head and neck cancer accounts for 4%. The increase in bacterial and viral infections worldwide affecting ear, nose, and throat health is also causing a rise in the demand for ENT diagnostic and surgical devices. For instance, according to the World Health Organization (WHO) data published in 2022, the probability of an individual facing long-term effects such as loss of hearing, speech, and communication after getting recovered from bacterial meningitis is 1 out of 5. Along with this the decrease or overall loss of hearing ability with increasing age requires immediate action in form of hearing aids and implants, for which surgeries are done eventually leading to the growth of the ENT devices market.

The other important factor for the ENT devices market growth is the new technological developments happening for effective but minimally invasive procedures at affordable costs. For instance, Georgia Tech researchers have developed affordable ultra-low-cost hearing aid to help millions of people suffering from age-related hearing loss.

The sedentary lifestyle is another driving factor for the ENT devices market growth as it leads to lifestyle-based diseases including obstructive sleep apnoea and other breathing problems. According to American Academy of Sleep Medicine, around 30 million American adults suffer from obstructive sleep apnoea (OSA). The acute and chronic cases of seasonal allergies including allergic rhinitis, and sinusitis owing to certain allergens also impact the ENT device market positively. As per the latest data available from World Allergy Organization 2020, currently around 400 million people are suffering from allergic rhinitis worldwide and most of them are neither diagnosed nor treated.

The ENT device market is also seeing positive growth due to the rise in cosmetic surgeries happening worldwide. People getting more inclined toward enhancing their physical appearances and the availability of minimally invasive and safe procedures at affordable rates are further driving the cosmetic surgery industry and thus leading to remarkable growth in the ENT devices market growth also.

However, the lack of skilled ENT specialists and limited access to affordable ENT products in developing nations are certain key factors hampering the ENT devices market growth.

During the period of the COVID-19 pandemic, the ENT device market growth has shown some decline due to shifted primary focus on first treating patients suffering from Coronavirus. The hospitals closed down the ENT department during the pandemic owing to lockdown and also to avoid any chance of spread of infection. However, as everything has been normalized post-COVID-19, and with the increase in public awareness of ENT health and regular check-ups, there is a growth in ENT surgeries. Thus, the market seems to grow effectively during the forecast period from 2024 to 2030.

ENT Devices Market Segment Analysis:

ENT Devices Market by Device type (Diagnostic ENT Devices, Surgical ENT Devices, Hearing Aids, Hearing Implants, Nasal Splints, and Others) Procedure type (Laryngoscopy, Functional Endoscopic Sinus Surgery, Tonsillectomy, Adenoidectomy, and Others) Usability (Disposable and Reusable), Age Group (Paediatric and Adults), End-User (Hospitals, ENT Clinics, and Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Based on the device type segment, hearing implants are going to register significant growth in revenue in the ENT devices market during the forecast period (2024-2030). This can be ascribed to the rising prevalence of hearing loss owing to factors such as aging, inappropriate use of drugs and medications, infections like rubella, syphilis, and jaundice, among others. For instance, according to World Health Organization (WHO) 2022, the probability of suffering even a slight degree of hearing loss by 2050 will be 1 out of 4.

Also, the technological advancement in form of artificial intelligence, small device size, and minimum invasiveness in solving hearing impairment can prove to be an important factor for hearing implant market growth. For example, according to National Institute on Deafness and Other Communication Disorders (2023), approximately 736,900 registered device implantation have been performed in December 2019 worldwide. This gives an insight into the hearing implant market growth.

Therefore, considering the growing demand for this product type, numerous new products are also being launched in the market. For instance, in August 2022 Cochlear Limited, pioneers in implantable hearing solutions announced the launch of the world's smallest off-the-ear cochlear implant sound processor Nucleus® Kanso® 2 in Singapore which helps in improving hearing in people with hearing loss. Therefore, considering the prevalence of hearing loss and the growing need for hearing implants among end-users, this product category is expected to generate considerable revenue thereby pushing the overall growth of the global ENT devices market during the forecast period.

North America is expected to dominate the overall ENT Devices Market:

The ENT device market is going to see prosperity in the North America region specifically owing to key factors including underlying diseases like cancer, allergic rhinitis, sinusitis, new technological advancements, high-tech medical facilities, government support, and awareness regarding ENT health among others.

The cases of allergic sinusitis are highly prevalent in the United States. Sinusitis is an illness of the nose and sinuses which is marked by symptoms like nasal blockage, inflammation, pain in the noses and sinuses, fever, nasal discharge, and others. According to the Centers for Disease Control and Prevention (CDC) 2022, around 28.9 million adults were diagnosed with sinusitis in the U.S in the year 2018. The large population affected by chronic sinusitis requires proper diagnosis and treatment in terms of surgery thereby driving the growth of the ENT devices market in the North America region.

Further, cases of hearing impairment are also on the rise owing to bacterial and viral infections, injuries, noise pollution, and a growing geriatric population. Hearing aids and cochlear implants are widely used for such problems in the country. According to the U.S. Food and Drug Administration (FDA) 2022, roughly around 118,100 and 65,000 cochlear implants have been implanted in adults and children respectively in the U.S. in the year 2019. This shows an enormous market growth opportunity for ENT devices in the U.S. region.

Thyroid cancer incidences are another key driver for growth in the ENT devices market in the region. For instance, according to the American Cancer Society 2022, the estimated number of new cases of thyroid cancer in the US for the year 2022 is 43,800 out of which 31,940 new cases in women and 11,860 in men. An adequate diagnosis and surgical treatments like minimally invasive, video-assisted thyroidectomy, endoscopic or robotic thyroidectomy are suggested by ENT specialists for thyroid surgery.

Head and neck cancer also drives the growth of the ENT devices market in the US. As per the National Cancer Institute 2022, estimated head and neck cancer cases diagnosed were more than 68,000 in the year 2023 in the United States.

Apart from general treatment options including surgery of the head and neck, and laryngectomy, sometimes plastic and reconstructive surgery may also require depending upon the severity and thus leading to an overall increase in the ENT devices market growth in the region.

ENT Devices Market Key Players:

Some of the key market players operating in the ENT Devices market include Medtronic, Starkey, Smith and Nephew Plc., Fude Technology Group Limited, Cochlear Limited, Olympus America, Stryker Corporation, Johnson & Johnson Services, Inc., Sonova Holding AG, Atos medical Ab, MED-EL Medical Electronics, Firefly Global, RION Co., Ltd., GN Store Nord A/S, Welch Allyn®, Karl Storz Gmbh & co., Demant A/S, B. Braun Melsungen AG, WS Audiology A/S, PENTAX Medical, among others.

Recent Developmental Activities in ENT Devices Market:

In January 2022, Cochlear Limited (ASX: COH) received U.S. Food and Drug Administration (FDA) approval for its Cochlear(TM) Nucleus® which offers an implant for unilateral hearing loss (UHL)/single-sided deafness (SSD).

In August 2022, 3NT Medical received U.S. Food and Drug Administration (FDA) approval for Peregrine Drivable ENT Scope which allows ENT specialists to visualize in-depth intra-sinus anatomy with minimal resection.

In November 2020, SafKan Health received FDA clearance for its OtoSet which is the first automated ear cleaning system.

Key Takeaways from the ENT Devices Market Report Study

• Market size analysis for current ENT devices market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the ENT devices market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global ENT devices market.
• Various opportunities are available for the other competitor in the ENT devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current ENT devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for ENT devices market growth in the coming future?

Target Audience who can be benefited from this ENT Devices Market Report Study

• ENT devices products providers
• Research organizations and consulting companies
• ENT devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in ENT devices
• Various end-users who want to know more about the ENT devices market and the latest technological developments in the ENT devices market.

Frequently Asked Questions for ENT Devices Market:

1. What are ENT devices?

ENT Devices are medical devices that are employed in the diagnosis, treatment, and management of ear, nose, and throat health.

2. What is the market for Global ENT devices?

The global ENT devices market was valued at USD 16.80 billion in 2023, growing at a CAGR of 6.89% during the forecast period from 2024 to 2030 to reach USD 25.02 billion by 2030.

3. What are the drivers for the global ENT devices Market?

The ENT device market is slated to witness prosperity owing to factors such as the growing prevalence of bacterial and viral infections, chronic diseases such as cancer, an increasingly sedentary lifestyle, a growing aging population base susceptible to the development of hearing loss, and the growing focus on improving the safety and usability of ENT devices for end-users are further expected to result in the appreciable revenue growth in the ENT devices market during the forecast period (2024-2030).

4. Who are the key players operating in the global ENT devices Market?

Some of the key market players operating in the ENT Devices market include Medtronic, Starkey, Smith and Nephew Plc., Fude Technology Group Limited, Cochlear Limited, Olympus America, Stryker Corporation, Johnson & Johnson Services, Inc., Sonova Holding AG, Atos medical Ab, MED-EL Medical Electronics, Firefly Global, RION Co., Ltd., GN Store Nord A/S, Welch Allyn®, Karl Storz Gmbh & co., Demant A/S, B. Braun Melsungen AG, WS Audiology A/S, PENTAX Medical, among others.

5. Which region has the highest share in the ENT devices market?

North America is expected to dominate the overall ENT devices market during the forecast period from 2024 to 2030. This can be ascribed to the presence of a large patient pool associated with hearing impairment, and chronic diseases like cancer, rhinitis, and sinusitis. The increase in obstructive sleep apnoea cases also increases the market for ENT devices in the region.

Table of Contents

1.ENT Devices Market Report Introduction

2.ENT Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. ENT Devices Market Key Factors Analysis

• 4.1. ENT Devices Market Drivers
  • 4.1.1. Rising ENT-related Problems
  • 4.1.2. Rising Geriatric Population
  • 4.1.3. Technological advancements
  • 4.1.4. Increase in Cosmetic Surgery
• 4.2. ENT Devices Market Restraints and Challenges
  • 4.2.1. A dearth of skilled ENT specialists
  • 4.2.2. Complications associated with ENT devices
• 4.3. ENT Devices Market Opportunities
  • 4.3.1. Improving Product Safety
  • 4.3.2. Affordable ENT products

5. ENT Devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on ENT Devices Market

7. ENT Devices Market Layout

• 7.1. By Device Type
  • 7.1.1. Diagnostic ENT Devices
  • 7.1.2. Surgical ENT Devices
  • 7.1.3. Hearing Aids
  • 7.1.4. Hearing Implants
  • 7.1.5. Nasal Splints
  • 7.1.6. Others
• 7.2. By Procedure
  • 7.2.1. Laryngoscopy
  • 7.2.2. Functional Endoscopic Sinus Surgery
  • 7.2.3. Tonsillectomy and Adenoidectomy
  • 7.2.4. Others
• 7.3. By Usability
  • 7.3.1. Disposable
  • 7.3.2. Reusable
• 7.4. By Age Group
  • 7.4.1. Pediatric
  • 7.4.2. Adults
• 7.5. By End-user
  • 7.5.1. Hospitals
  • 7.5.2. ENT Clinics
  • 7.5.3. Others
• 7.6. By Geography
  • 7.6.1. North America
    • 7.6.1.1. United States ENT Devices Market in USD million (2021-2030)
    • 7.6.1.2. Canada ENT Devices Market in USD million (2021-2030)
    • 7.6.1.3. Mexico ENT Devices Market in USD million (2021-2030)
  • 7.6.2. Europe
    • 7.6.2.1. France ENT Devices Market in USD million (2021-2030)
    • 7.6.2.2. Germany ENT Devices Market in USD million (2021-2030)
    • 7.6.2.3. United Kingdom ENT Devices Market in USD million (2021-2030)
    • 7.6.2.4. Italy ENT Devices Market in USD million (2021-2030)
    • 7.6.2.5. Spain ENT Devices Market in USD million (2021-2030)
    • 7.6.2.6. Russia ENT Devices Market in USD million (2021-2030)
    • 7.6.2.7. Rest of Europe ENT Devices Market in USD million (2021-2030)
  • 7.6.3. Asia-Pacific
    • 7.6.3.1. China ENT Devices Market in USD million (2021-2030)
    • 7.6.3.2. Japan ENT Devices Market in USD million (2021-2030)
    • 7.6.3.3. India ENT Devices Market in USD million (2021-2030)
    • 7.6.3.4. Australia ENT Devices Market in USD million (2021-2030)
    • 7.6.3.5. South Korea ENT Devices Market in USD million (2021-2030)
    • 7.6.3.6. Rest of Asia Pacific ENT Devices Market in USD million (2021-2030)
  • 7.6.4. Rest of the World (RoW)
    • 7.6.4.1. Middle East ENT Devices Market in USD million (2021-2030)
    • 7.6.4.2. Africa ENT Devices Market in USD million (2021-2030)
    • 7.6.4.3. South America ENT Devices Market in USD million (2021-2030)

8. ENT Devices Market Global Company Share Analysis - Key 3-5 Companies

9. ENT Services Market Company and Product Profiles

• 9.1. Medtronic
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Starkey
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Johnson & Johnson Services, Inc.
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Smith and Nephew Plc.
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Fude Technology Group Limited
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. Cochlear Limited
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Olympus America
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.6. Product Listing
  • 9.7.5. Entropy
• 9.8. Stryker Corporation
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Sonova Holding AG
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Atos medical Ab
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. MED-EL Medical Electronics
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Firefly Global
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. RION Co., Ltd.
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. GN Store Nord A/S
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. Welch Allyn®
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. Karl Storz Gmbh & co.
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. Demant A/S
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.6. Product Listing
  • 9.17.5. Entropy
• 9.18. B. Braun Melsungen AG
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. WS Audiology A/S
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20. PENTAX Medical
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us